Forbes J M & CO LLP Bristol Myers Squibb CO Transaction History

Forbes J M & CO LLP

$1 Billion
Q3 2024

A detailed history of Forbes J M & CO LLP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Forbes J M & CO LLP holds 8,027 shares of BMY stock, worth $467,412. This represents 0.04% of its overall portfolio holdings.

Number of Shares

8,027

Previous 9,255 13.27%

Holding current value

$467,412

Previous $384,000 8.07%

% of portfolio

0.04%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$39.66 - $51.75 $48,702 - $63,549	-1,228 Reduced 13.27%	8,027 $415,000
Q2 2024 Jul 30, 2024	SELL	$40.25 - $52.99 $5.27 Million - $6.94 Million	-131,014 Reduced 93.4%	9,255 $384,000
Q1 2024 Apr 11, 2024	SELL	$47.98 - $54.4 $268,208 - $304,096	-5,590 Reduced 3.83%	140,269 $7.61 Million
Q4 2023 Feb 08, 2024	BUY	$48.48 - $57.85 $46,346 - $55,304	956 Added 0.66%	145,859 $7.48 Million
Q3 2023 Nov 02, 2023	BUY	$57.89 - $64.73 $45,212 - $50,554	781 Added 0.54%	144,903 $8.41 Million
Q2 2023 Aug 03, 2023	SELL	$63.71 - $70.74 $96,202 - $106,817	-1,510 Reduced 1.04%	144,122 $9.22 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $253,903 - $287,983	3,864 Added 2.73%	145,632 $10.1 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $24,241 - $28,705	354 Added 0.25%	141,768 $10.2 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $287 - $170,046	2,213 Added 1.59%	141,414 $10.1 Million
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $11,764 - $12,956	-162 Reduced 0.12%	139,201 $10.7 Million
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $50,536 - $60,597	822 Added 0.59%	139,363 $10.2 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $22,739 - $26,508	-424 Reduced 0.31%	138,541 $8.64 Million
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $118,458 - $138,758	2,002 Added 1.46%	138,965 $8.22 Million
Q2 2021 Aug 03, 2021	BUY	$61.91 - $67.42 $8,543 - $9,303	138 Added 0.1%	136,963 $9.15 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $171,373 - $192,745	2,888 Added 2.16%	136,825 $8.64 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $11,259 - $12,758	195 Added 0.15%	133,937 $8.31 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $96,826 - $107,297	1,686 Added 1.28%	133,742 $8.06 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $149,932 - $175,286	2,735 Added 2.11%	132,056 $7.77 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $206,665 - $300,333	-4,454 Reduced 3.33%	129,321 $7.21 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $6.01 Million - $7.83 Million	122,050 Added 1040.94%	133,775 $8.59 Million
Q3 2019 Nov 07, 2019	BUY	$42.77 - $50.71 $8,554 - $10,142	200 Added 1.74%	11,725 $595,000
Q3 2018 Nov 02, 2018	SELL	$55.19 - $62.25 $108,834 - $122,757	-1,972 Reduced 14.61%	11,525 $715,000
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $1,819 - $2,267	-36 Reduced 0.27%	13,497 $747,000
Q1 2018 Apr 18, 2018	SELL	$59.92 - $68.98 $4,194 - $4,828	-70 Reduced 0.51%	13,533 $856,000
Q4 2017 Feb 09, 2018	SELL	$59.94 - $65.35 $29,070 - $31,694	-485 Reduced 3.44%	13,603 $834,000
Q3 2017 Nov 13, 2017	SELL	$55.23 - $63.74 $10,217 - $11,791	-185 Reduced 1.3%	14,088 $897,000
Q2 2017 Aug 10, 2017	BUY	N/A	14,273	14,273 $795,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forbes J M & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Forbes J M & CO LLP with notifications on news.

Account